RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shionogi & Co Stock

Shionogi & Co Debt 2024

Shionogi & Co Debt

-346,470 JPY

Ticker

4507.T

ISIN

JP3347200002

WKN

855648

In 2024, Shionogi & Co's total debt was -346,470 JPY, a 94.92% change from the -177,746 JPY total debt recorded in the previous year.

Shionogi & Co Aktienanalyse

What does Shionogi & Co do?

The company Shionogi & Co Ltd is a Japanese pharmaceutical company based in Osaka. It was founded in 1878 and has since become a significant player in the industry. It currently employs over 6,000 employees worldwide and is listed on the Tokyo Stock Exchange. Shionogi is divided into several business segments that offer different products and services. The largest segment is the pharmaceutical division, which specializes in the development and marketing of drugs. The company has strong expertise in infectious diseases, pain management, and oncology, and operates in many countries worldwide. One flagship product is the antibiotic Cefditoren, used to treat various bacterial infections. In addition to the pharmaceutical division, Shionogi is also active in other areas. For example, the company offers diagnostic and laboratory services, operating multiple labs in Japan and other countries. Another business segment is the production and marketing of nutritional supplements, sold in Japan, China, and the USA. Shionogi's business model is based on extensive research and development, as well as strong brand positioning. The company invests a significant portion of its revenue each year in the research and development of new drugs and better treatment options for existing diseases. Thanks to the high quality of its products and strong brand, the company has a loyal customer base. In recent years, Shionogi has focused on international expansion opportunities and has expanded its activities in various regions. For example, it has partnered with US pharmaceutical company Purdue Pharma to develop and market a novel pain medication. Shionogi's annual revenue is around 1.5 billion euros. The company is particularly strong in Japan and other Asian countries, but is also active in the US and Europe. In the coming years, Shionogi aims to further expand its international business and solidify its position as a significant player in the industry. Key focuses will be on the launch of new products and finding treatments for previously incurable diseases. Overall, Shionogi is an innovative and successful company that utilizes its expertise in the pharmaceutical industry in various ways. With its dedicated employees and strong brand, it will continue to play an important role in the industry. Shionogi & Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Shionogi & Co's Debt Structure

Shionogi & Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Shionogi & Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Shionogi & Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Shionogi & Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Shionogi & Co stock

What is the debt of Shionogi & Co this year?

Shionogi & Co has a debt level of -346,470 JPY this year.

What was the debt of Shionogi & Co compared to the previous year?

The debt of Shionogi & Co has increased by 94.92% compared to the previous year increased.

What are the consequences of high debt for investors in Shionogi & Co?

High debt can pose a risk for investors of Shionogi & Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Shionogi & Co?

Low debt means that Shionogi & Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Shionogi & Co affect the company?

An increase in debt of Shionogi & Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Shionogi & Co affect the company?

A reduction in debt of Shionogi & Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Shionogi & Co?

Some factors that can influence the debt of Shionogi & Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Shionogi & Co so important for investors?

The debts of Shionogi & Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Shionogi & Co take to change the debt?

To change the debt, Shionogi & Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Shionogi & Co pay?

Over the past 12 months, Shionogi & Co paid a dividend of 170 JPY . This corresponds to a dividend yield of about 2.56 %. For the coming 12 months, Shionogi & Co is expected to pay a dividend of 183.81 JPY.

What is the dividend yield of Shionogi & Co?

The current dividend yield of Shionogi & Co is 2.56 %.

When does Shionogi & Co pay dividends?

Shionogi & Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Shionogi & Co?

Shionogi & Co paid dividends every year for the past 23 years.

What is the dividend of Shionogi & Co?

For the upcoming 12 months, dividends amounting to 183.81 JPY are expected. This corresponds to a dividend yield of 2.76 %.

In which sector is Shionogi & Co located?

Shionogi & Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shionogi & Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shionogi & Co from 12/1/2024 amounting to 85 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Shionogi & Co pay the last dividend?

The last dividend was paid out on 12/1/2024.

What was the dividend of Shionogi & Co in the year 2023?

In the year 2023, Shionogi & Co distributed 150 JPY as dividends.

In which currency does Shionogi & Co pay out the dividend?

The dividends of Shionogi & Co are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shionogi & Co

Our stock analysis for Shionogi & Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shionogi & Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.